Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Omnicell Community
NasdaqGS:OMCL Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Omnicell
Popular
Undervalued
Overvalued
Omnicell
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Near-shoring And Digitization Will Drive Stability Despite Tariff Challenges
Key Takeaways Supply chain improvements and near-shoring are expected to offset cost pressures, while a shift to recurring SaaS and services enhances earnings stability and valuation potential. Rising healthcare digitization and demand for pharmacy automation align with Omnicell's solutions, supporting competitive edge and long-term growth as care shifts beyond hospitals.
View narrative
US$43.83
FV
29.1% undervalued
intrinsic discount
2.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
15 days ago
author updated this narrative
Your Valuation for
OMCL
OMCL
Omnicell
Your Fair Value
US$
Current Price
US$31.09
37.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-23m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.3b
Earnings US$27.0m
Advanced
Set Fair Value